FindTrial
Sign In

Antibiotic resistance genes in neonatal sepsis

Antibiotic resistance by a polymerase chain reaction panel in neonatal sepsis– a prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058633
Enrollment
73
Registered
2023-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P369- Bacterial sepsis of newborn, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

KIMSHEALTH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All sick neonates (based on defined clinical or laboratory criteria) investigated for sepsis AND 2. Who have a report on PCR panel for resistance genes.

Exclusion criteria

Exclusion criteria: Neonates whose parents did not consent for sharing their baby’s data

Design outcomes

Primary

MeasureTime frame
The proportion of babies having any one resistance gene on PCR panelTimepoint: at the time of investigation—

Secondary

MeasureTime frame
1. Comparison of the proportion of babies with good short term clinical outcomes (survival till discharge without neurodevelopmental disability) among babies with / without gene resistance 2.Association between potential risk factors & gene resistance.Timepoint: At discharge—

Countries

India

Contacts

Public ContactDr Naveen Jain

KERALA INSTITUTE OF MEDICAL SCIENCE

naveen_19572@outlook.com9387814568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026